Explore how filgotinib, a selective JAK inhibitor, offers new hope for Japanese patients with refractory rheumatoid arthritis who haven't responded to biologic DMARDs.
Discover how filgotinib provides rapid relief from pain and fatigue while improving quality of life for rheumatoid arthritis patients with inadequate response to biologic DMARDs.
New research reveals surprising patterns in methotrexate maintenance when combined with advanced rheumatoid arthritis therapies, challenging conventional treatment approaches.